The latest results of clinical trials of more than 125 patients testing an investigational personalized cellular therapy known as CTL019 was presented by a University of Pennsylvania research team at...
New kind of targeted drug shows promise for leukemia patients
12/10/2014
A new type of cancer therapy that targets an oncometabolite produced dramatic results in patients with advanced leukemia in an early-phase clinical trial. The study, led by Eytan M.
Researchers find clue to halting metastasis in multiple myeloma
12/10/2014
Although it is among the most highly metastatic of all cancers, multiple myeloma is driven to spread by only a subset of the myeloma cells within a patient's body, researchers at Dana-Farber Cancer...
America's health rankings findings: who takes the crown as healthiest state?
12/10/2014
Find out the healthiest and least healthy states in 2014, according to America's Health Rankings, together with disturbing news of rising rates of obesity and physical inactivity.
Promising results from stem cell transplant without radiation or chemotherapy
12/10/2014
Researchers at Dana-Farber/Boston Children's Cancer and Blood Disorders Center report promising outcomes from a clinical trial with patients with a rare form of bone marrow failure who received a...
New signaling role for key protein may contribute to wound healing, tumor growth
12/10/2014
A key protein may represent a new way to use the immune system to speed healing and counter inflammatory, infectious and autoimmune diseases, according to study led by researchers at the Icahn School...
Pilot study engineers pediatric patients' own immune cells to hunt down cancer cells in blood
12/10/2014
An innovative cell therapy against a highly aggressive form of acute lymphoblastic leukemia (ALL) continues to show highly promising results in children treated in a pilot study.
Hodgkin lymphoma patients benefit from immunotherapy drugs
12/10/2014
In recent years, a number of scientific breakthroughs have led to the development of drugs that unleash the power of the immune system to recognize and attack cancer.
In multiple myeloma patients, unprecedented benefit seen in test of three-drug treatment
12/10/2014
In the treatment of multiple myeloma, the addition of carfilzomib to a currently accepted two-drug combination produced significantly better results than using the two drugs alone, according to a...
Prognostic tool for multiple myeloma may be provided by circulating RNA
12/10/2014
The "molecular mail" sent by multiple myeloma cells provides clues to how well patients with the disease are likely to respond to treatment, according to a study presented at the annual meeting of...